Titan Pharmaceuticals Inc (OTCBB - OTCQB:TTNP)

0.63
Delayed Data
As of Mar 26
 -0.01 / -1.56%
Today’s Change
0.44
Today|||52-Week Range
0.87
+36.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues10.1M4.1M7.1M10.5M
 
 
 
 
 
Cost of Goods Sold12.8M11.2M0.00--
 
 
 
Depreciation And Amortization85.0K32.0K17.0K107.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.8M-7.1M7.1M--
 
 
 
 
General Expenses3.3M3.4M15.5M11.3M
 
 
 
 
 
Research And Development----10.6M8.3M
 
 
 
Total Operating Expenses16.1M14.6M15.5M11.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.0M-10.5M-8.4M-891.0K
 
 
 
 
 
Extraordinary Credit0.001.9M0.0012.6M
 
 
 
Extraordinary Charge0.000.00-1.8M0.00
 
 
Interest Expense On Debt678.0K6.4M4.9M1.6M
 
 
 
 
 
Other Expenses-131.0K-129.0K-183.0K-467.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.8M-15.2M-15.2M9.7M
 
 
 
 
 
Net Income-5.6M-15.2M-15.2M9.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS59.2M59.3M66.5M82.1M
 
 
 
 
 
Shares To Calculate EPS Diluted59.2M59.3M66.5M82.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.26-$0.23$0.10
 
 
 
 
 
EPS Diluted-$0.09-$0.26-$0.23$0.10
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account